Reuven Ishai1,2, Mohammad Seyyedi1,2, Andrew M Chancellor3, Catriona A McLean4, Michael L Rodriguez5, Gabor Michael Halmagyi6, Joseph B Nadol1,2, David J Szmulewicz7, Alicia M Quesnel1,2. 1. Otopathology Laboratory, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear. 2. Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA. 3. Department of Medicine, Tauranga Hospital, Tauranga, New Zealand. 4. Department of Anatomic Pathology, Alfred Hospital, Melbourne. 5. Australian School of Advanced Medicine, Macquarie University, NSW. 6. Department of Pathology, Royal Prince Alfred Hospital, Sydney. 7. Balance Disorders and Ataxia Service, Royal Victoria Eye and Ear Hospital, Melbourne, Australia.
Abstract
OBJECTIVE: To describe the site of lesion responsible for the severe, bilateral, symmetrical, selective loss of vestibular function in Cerebellar Ataxia with Neuronopathy and Vestibular Areflexia Syndrome (CANVAS), an adult-onset recessively-inherited ataxia, characterized by progressive imbalance due to a combination of cerebellar, somatosensory, and selective vestibular impairment with normal hearing. METHODS: Histologic examination of five temporal bones and the brainstems from four CANVAS patients and the brainstem only from one more, each diagnosed and followed from diagnosis to death by one of the clinician authors. RESULTS: All five temporal bones showed severe loss of vestibular ganglion cells (cell counts 3-16% of normal), and atrophy of the vestibular nerves, whereas vestibular receptor hair cells and the vestibular nuclei were preserved. In contrast, auditory receptor hair cells, the auditory ganglia (cell counts 51-100% of normal), and the auditory nerves were relatively preserved. In addition, the cranial sensory ganglia (geniculate and trigeminal), present in two temporal bones, also showed severe degeneration. CONCLUSIONS: In CANVAS there is a severe cranial sensory ganglionopathy neuronopathy (ganglionopathy) involving the vestibular, facial, and trigeminal ganglia but sparing the auditory ganglia. These observations, when coupled with the known spinal dorsal root ganglionopathy in CANVAS, indicate a shared pathogenesis of its somatosensory and cranial nerve manifestations. This is the first published account of both the otopathology and neuropathology of CANVAS, a disease that involves the central as well as the peripheral nervous system.
OBJECTIVE: To describe the site of lesion responsible for the severe, bilateral, symmetrical, selective loss of vestibular function in Cerebellar Ataxia with Neuronopathy and Vestibular Areflexia Syndrome (CANVAS), an adult-onset recessively-inherited ataxia, characterized by progressive imbalance due to a combination of cerebellar, somatosensory, and selective vestibular impairment with normal hearing. METHODS: Histologic examination of five temporal bones and the brainstems from four CANVAS patients and the brainstem only from one more, each diagnosed and followed from diagnosis to death by one of the clinician authors. RESULTS: All five temporal bones showed severe loss of vestibular ganglion cells (cell counts 3-16% of normal), and atrophy of the vestibular nerves, whereas vestibular receptor hair cells and the vestibular nuclei were preserved. In contrast, auditory receptor hair cells, the auditory ganglia (cell counts 51-100% of normal), and the auditory nerves were relatively preserved. In addition, the cranial sensory ganglia (geniculate and trigeminal), present in two temporal bones, also showed severe degeneration. CONCLUSIONS: In CANVAS there is a severe cranial sensory ganglionopathy neuronopathy (ganglionopathy) involving the vestibular, facial, and trigeminal ganglia but sparing the auditory ganglia. These observations, when coupled with the known spinal dorsal root ganglionopathy in CANVAS, indicate a shared pathogenesis of its somatosensory and cranial nerve manifestations. This is the first published account of both the otopathology and neuropathology of CANVAS, a disease that involves the central as well as the peripheral nervous system.
Authors: David J Szmulewicz; Leslie Roberts; Catriona A McLean; Hamish G MacDougall; G Michael Halmagyi; Elsdon Storey Journal: Neurol Clin Pract Date: 2016-02
Authors: David J Szmulewicz; Catriona A McLean; Hamish G MacDougall; Leslie Roberts; Elsdon Storey; G Michael Halmagyi Journal: J Vestib Res Date: 2014 Impact factor: 2.435
Authors: David J Szmulewicz; Linda Seiderer; G Michael Halmagyi; Elsdon Storey; Leslie Roberts Journal: Muscle Nerve Date: 2015-01-05 Impact factor: 3.217
Authors: H Adle-Biassette; J E Bell; A Creange; V Sazdovitch; F J Authier; F Gray; J J Hauw; R Gherardi Journal: Neuropathol Appl Neurobiol Date: 1998-10 Impact factor: 8.090
Authors: Teddy Y Wu; Jennifer M Taylor; Dean H Kilfoyle; Andrew D Smith; Ben J McGuinness; Mark P Simpson; Elizabeth B Walker; Peter S Bergin; James C Cleland; David O Hutchinson; Neil E Anderson; Barry J Snow; Tim J Anderson; Laura A F Paermentier; Nick J Cutfield; Andrew M Chancellor; Stuart S Mossman; Richard H Roxburgh Journal: Brain Date: 2014-07-28 Impact factor: 13.501
Authors: Haloom Rafehi; David J Szmulewicz; Mark F Bennett; Nara L M Sobreira; Kate Pope; Katherine R Smith; Greta Gillies; Peter Diakumis; Egor Dolzhenko; Michael A Eberle; María García Barcina; David P Breen; Andrew M Chancellor; Phillip D Cremer; Martin B Delatycki; Brent L Fogel; Anna Hackett; G Michael Halmagyi; Solange Kapetanovic; Anthony Lang; Stuart Mossman; Weiyi Mu; Peter Patrikios; Susan L Perlman; Ian Rosemergy; Elsdon Storey; Shaun R D Watson; Michael A Wilson; David S Zee; David Valle; David J Amor; Melanie Bahlo; Paul J Lockhart Journal: Am J Hum Genet Date: 2019-06-20 Impact factor: 11.025
Authors: Rachael L Taylor; Tonci Antunovich; Thomas Ming Hong Chang; Miriam Rodrigues; Ashleigh Baker; Peter Bergin; Ben McGuinness; Richard H Roxburgh Journal: J Neurol Date: 2022-10-22 Impact factor: 6.682
Authors: Leslie J Roberts; Michael McVeigh; Linda Seiderer; Ian H Harding; Louise A Corben; Martin Delatycki; David J Szmulewicz Journal: Neurol Genet Date: 2022-09-28